Molecular advances in pancreatic cancer

Digestion
N R Lemoine

Abstract

Our understanding of the molecular genetics of pancreatic cancer has advanced spectacularly over the last 5 years so that this tumour type is now one of the best characterised of all malignancies. A small proportion of cases results from inherited predisposition due to germline transmission of a mutated CDKN2 or BRCA2 gene, while patients with familial pancreatitis due to a mutated cationic trypsinogen gene have a greatly increased risk of developing pancreatic cancer. The majority of cases are sporadic and are characterised at the molecular level by several key genetic abnormalities. The most frequent of these is point mutation of the dominant oncogene KRAS, a lesion which occurs as an early and possibly initiating event in tumourigenesis. Inactivating mutations of the tumour suppressor genes TP53, CDKN2 and SMAD4 are also frequently observed and this constellation of genetic defects sets pancreatic cancer apart from other types of cancer, a feature which could have important implications for molecular diagnosis. Genetic intervention for cancer prevention and therapy is becoming a clinical reality and several approaches are being pursued for pancreatic cancer. As well as tumour suppressor gene replacement and oncogene blockade...Continue Reading

Citations

Aug 10, 2000·The British Journal of Surgery·M ManuS Bramhall
Oct 7, 2006·Current Opinion in Gastroenterology·R H HrubanS E Kern
Jan 13, 2001·Gut·E EfthimiouT A Brentnall
Apr 19, 2011·Molecular Cancer Research : MCR·Seung-Hee LeePamela Itkin-Ansari
Sep 27, 2001·World Journal of Surgery·R K KasperkV Schumpelick
Oct 15, 2008·Expert Opinion on Therapeutic Targets·Devalingam Mahalingam, Francis Giles
May 27, 2009·Expert Opinion on Emerging Drugs·Devalingam MahalingamFrancis J Giles
Nov 4, 2000·Expert Opinion on Investigational Drugs·S R Bramhall
Sep 20, 2015·Gastroenterology·Erik S KnudsenAgnieszka K Witkiewicz
Nov 27, 2004·Journal of Surgical Oncology·Desiree PantaloneFrancesca Torricelli
Nov 6, 2004·Gastroenterology Clinics of North America·Randall E Brand, Henry T Lynch
Aug 20, 2004·Internal Medicine Journal·D GoldsteinG Keogh
Dec 22, 1999·Medizinische Klinik·M BöhmigS Rosewicz
Nov 13, 2001·Oncogene·T Crnogorac-JurcevicN R Lemoine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.